Alloferon 1

General Information


DRACP ID  DRACP00052

Peptide Name   Alloferon 1

Sequence  HGVSGHGQHGVHG

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  the blow fly Calliphora vicina (Diptera)

Type  Native peptide

Classification

  

Active ACP Immune system stimulating peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia lower doses of cancer cells could be eliminated after administration of 25 μg of alloferon Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  (i) stimulates natural cytotoxicity of human peripheral blood lymphocytes, (ii) induces IFN synthesis in mouse and human models, and (iii) enhances antiviral and antitumor resistance in mice.

Nature  Anticancer; Antitumor; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00052

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C52H76N22O16

Absent amino acids  ACDEFIKLMNPRTWY

Common amino acids  G

Mass  147955

Pl  7.88

Basic residues  4

Acidic residues  0

Hydrophobic residues  2

Net charge  4

Boman Index  -1480

Hydrophobicity  -82.31

Aliphatic Index  44.62

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12235362

Title  Antiviral and antitumor peptides from insects

Doi 10.1073/pnas.192301899

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.